This is the blog for CARG, the Coronary Artery Rehabilitation Group, based in Saskatoon, Saskatchewan, Canada. It will contain items of interest to CARG's own members and anybody else interested in the latest news about rehabilitation and heart-related matters. Canadian charitable number: 89675 0163 RR 0001 || e-mail: carg.ca@gmail.com || website: carg.ca || Blog disclaimer
Showing posts with label Germany. Show all posts
Showing posts with label Germany. Show all posts
Friday, December 24, 2010
Wood stoves in Germany shortens lives
Tuesday, April 6, 2010
Cardiology: protecting heart muscle cells from death
A team of researchers, led by Uta Hoppe, at the University of Cologne, Germany, has identified a role for the protein connexin 43 in protecting mouse heart muscle cells from death. The team therefore suggests that it might be an attractive target for therapies that help protect cells from injuries that normally result in death, such as the injuries suffered by cells as a result of heart attack. Several lines of evidence indicate that the PKC protein and mitoKATP potassium channels in the inner mitochondrial membrane have a central role in protecting cells from death. In the study, connexin 43 was found to be required for mitoKATP activation of PKC. Importantly, this pathway was crucial for protecting mouse heart muscle cells from death. The research appears in the Journal of Clinical Investigation - Science Daily
Tuesday, March 16, 2010
Impotence 'strong predictor' of heart attacks
Friday, January 1, 2010
Procedure boosts outcomes in implantable defibrillator patients (Germany)
"Heart patients with a dangerous rapid heartbeat called ventricular tachycardia often get implantable cardiac defibrillators to help control the condition, and a new study suggests that they will have fewer recurrences of the abnormality if they undergo a procedure called catheter ablation before they receive the device. Reporting December 31 in The Lancet, researchers at Asklepios Klinik St. Georg in Hamburg, Germany, looked at 107 patients aged 18 to 80, all of whom had had a previous heart attack, an episode of stable ventricular tachycardia and reduced left-ventricular function. Participants were assigned to receive implantable defibrillators either alone or along with catheter ablation, a procedure that destroys faulty tissue within the heart linked to irregular heartbeats. The patients' outcomes were followed for an average of close to two years" - HealthDay
Friday, November 21, 2008
US teenager lives 118 days without heart
Thursday, November 20, 2008
EUROPACE 2009
"EUROPACE is the official Congress of the European Heart Rhythm Association, a Registered Branch of the European Society of Cardiology. EUROPACE has now established itself as the foremost European meeting on cardiac arrhythmias and pacing. Over 4,000 participants attended the last meeting. The increasingly strong international attendance confirms that interest in EUROPACE now reaches far beyond our Europe borders" - 21-24 June, 2009 - Berlin, Germany
Subscribe to:
Posts (Atom)